VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 39 filers reported holding VASCULAR BIOGENICS LTD in Q1 2018. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $28,000 | +12.0% | 21,000 | 0.0% | 0.00% | – |
| Q4 2019 | $25,000 | -16.7% | 21,000 | -4.5% | 0.00% | – |
| Q3 2019 | $30,000 | +3.4% | 22,000 | 0.0% | 0.00% | – |
| Q2 2019 | $29,000 | -12.1% | 22,000 | 0.0% | 0.00% | – |
| Q1 2019 | $33,000 | +57.1% | 22,000 | 0.0% | 0.00% | – |
| Q4 2018 | $21,000 | -41.7% | 22,000 | 0.0% | 0.00% | – |
| Q3 2018 | $36,000 | -26.5% | 22,000 | -0.5% | 0.00% | – |
| Q2 2018 | $49,000 | +25.6% | 22,100 | +30.0% | 0.00% | – |
| Q1 2018 | $39,000 | +333.3% | 17,000 | +750.0% | 0.00% | – |
| Q2 2017 | $9,000 | -18.2% | 2,000 | 0.0% | 0.00% | – |
| Q1 2017 | $11,000 | +10.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2016 | $10,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2016 | $10,000 | +11.1% | 2,000 | 0.0% | 0.00% | – |
| Q2 2016 | $9,000 | +28.6% | 2,000 | 0.0% | 0.00% | – |
| Q1 2016 | $7,000 | -36.4% | 2,000 | 0.0% | 0.00% | – |
| Q4 2015 | $11,000 | -83.6% | 2,000 | -77.8% | 0.00% | -100.0% |
| Q3 2015 | $67,000 | – | 9,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 896,771 | $2,063,000 | 2.12% |
| PURA VIDA INVESTMENTS, LLC | 100,000 | $230,000 | 0.14% |
| 683 Capital Management, LLC | 400,000 | $920,000 | 0.08% |
| DLD Asset Management, LP | 244,500 | $555,000 | 0.05% |
| ARK Investment Management | 75,354 | $173,000 | 0.01% |
| Virtu Financial LLC | 68,222 | $157,000 | 0.01% |
| IFP Advisors, Inc | 19,567 | $139,000 | 0.01% |
| FIDUCIARY TRUST INTERNATIONAL LLC | 11,050 | $25,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 19,614 | $43,000 | 0.00% |
| A.R.T. Advisors, LLC | 37,782 | $86,000 | 0.00% |